Skip to main content
Article
Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397).
American Journal of Clinical Oncology (2016)
  • Paul L. Moots, Vanderbilt University
  • Anne O’Neill, Harvard University
  • Harold Londer
  • Minesh Mehta, University of Maryland, Baltimore
  • Deborah T. Blumenthal, West Virginia University
  • Geoffrey R. Barger, Wayne State University
  • Margaret L. Grunnet, University of Connecticut
  • Stuart Grossman, Johns Hopkins University
  • Mark R. Gilbert, University of Texas MD Anderson Cancer Center
  • David Schiff, University of Virginia
Publication Date
January 9, 2016
DOI
10.1097/COC.0000000000000326
Citation Information
Paul L. Moots, Anne O’Neill, Harold Londer, Minesh Mehta, et al.. "Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397)." American Journal of Clinical Oncology (2016) p. 1
Available at: http://works.bepress.com/minesh-mehta/96/